{"id":285835,"date":"2026-10-05T10:17:03","date_gmt":"2026-10-05T04:47:03","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=285835"},"modified":"2026-10-05T10:17:03","modified_gmt":"2026-10-05T04:47:03","slug":"neulandlab-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/","title":{"rendered":"Is Neuland Laboratories the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Neuland Laboratories CMP Rs 21,500 (05 Oct 2026). Market cap Rs 27,580 Cr. ROE 19.42%. P\/E 55.41x versus Industry P\/E 37.53x.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Neuland Laboratories is one of the names investors compare when screening the Healthcare sector, built on a 19.42% return on equity and a P\/E of 55.41x against an Industry P\/E of 37.53x. Whether Neuland Laboratories is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n<p>Is <a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories<\/a> the best stock in its sector? The stock trades on the NSE at Rs 21,500 as of 05 October 2026, within its 52-week range of Rs 11,500.00 to Rs 24,225.00. Neuland Laboratories Ltd manufactures active pharmaceutical ingredients and provides custom manufacturing services to pharmaceutical companies.<\/p>\n<p>Neuland Laboratories sits in the Healthcare sector, and its 19.42% ROE and 55.41x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector&#8217;s Industry P\/E benchmark.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/abbott-india-best-stock-in-its-sector\">Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=neulandlab-best-stock-in-its-sector\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#About_Neuland_Laboratories\" title=\"About Neuland Laboratories\">About Neuland Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#Is_Neuland_Laboratories_the_Best_Stock_in_Its_Sector\" title=\"Is Neuland Laboratories the Best Stock in Its Sector?\">Is Neuland Laboratories the Best Stock in Its Sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#How_Neuland_Laboratories_Compares_Against_Its_Healthcare_Sector_Peers\" title=\"How Neuland Laboratories Compares Against Its Healthcare Sector Peers\">How Neuland Laboratories Compares Against Its Healthcare Sector Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#What_Makes_Neuland_Laboratories_Worth_Watching_in_Healthcare\" title=\"What Makes Neuland Laboratories Worth Watching in Healthcare\">What Makes Neuland Laboratories Worth Watching in Healthcare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#Neuland_Laboratories_Valuation_Is_It_Justified\" title=\"Neuland Laboratories Valuation: Is It Justified?\">Neuland Laboratories Valuation: Is It Justified?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#How_to_Track_Neuland_Laboratories_Before_You_Invest\" title=\"How to Track Neuland Laboratories Before You Invest\">How to Track Neuland Laboratories Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#Is_Neuland_Laboratories_the_best_stock_in_its_sector\" title=\"Is Neuland Laboratories the best stock in its sector?\">Is Neuland Laboratories the best stock in its sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#What_is_the_current_share_price_of_Neuland_Laboratories\" title=\"What is the current share price of Neuland Laboratories?\">What is the current share price of Neuland Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#What_sector_does_Neuland_Laboratories_belong_to\" title=\"What sector does Neuland Laboratories belong to?\">What sector does Neuland Laboratories belong to?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#How_does_Neuland_Laboratories_compare_to_its_sector_peers_on_PE\" title=\"How does Neuland Laboratories compare to its sector peers on P\/E?\">How does Neuland Laboratories compare to its sector peers on P\/E?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#What_is_Neuland_Laboratoriess_return_on_equity\" title=\"What is Neuland Laboratories&#8217;s return on equity?\">What is Neuland Laboratories&#8217;s return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/neulandlab-best-stock-in-its-sector\/#Should_I_invest_in_Neuland_Laboratories_based_on_its_sector_position\" title=\"Should I invest in Neuland Laboratories based on its sector position?\">Should I invest in Neuland Laboratories based on its sector position?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Neuland_Laboratories\"><\/span><strong>About Neuland Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neuland Laboratories Ltd manufactures active pharmaceutical ingredients and provides custom manufacturing services to pharmaceutical companies. The stock is trading about 11 percent below its 52-week high after nearly doubling from its 52-week low, and it trades at a very high absolute share price. At a market capitalisation of Rs 27,580 Cr, it is tracked as part of the Healthcare sector on Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Neuland_Laboratories_the_Best_Stock_in_Its_Sector\"><\/span><strong>Is Neuland Laboratories the Best Stock in Its Sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neuland Laboratories makes its case as the best stock in its sector primarily on return on equity and balance sheet strength, combining a 19.42% ROE with a 55.41x P\/E against the sector&#8217;s 37.53x Industry P\/E. Neuland Laboratories&#8217; 55.41x P\/E is above the 37.53x Industry P\/E, a premium built on a strong 19.42% ROE, though a 14.72x price to book leaves little room for disappointment.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Metric<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Neuland Laboratories<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">CMP (NSE)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 21,500.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">52-Week High \/ Low<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 24,225.00 \/ Rs 11,500.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Market Cap<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 27,580 Cr<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/E (TTM) vs Industry P\/E<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">55.41x vs 37.53x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/B<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">14.72<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">ROE<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">19.42%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">EPS (TTM)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 387.98<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Dividend Yield<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.16%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Debt to Equity<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.16<\/td>\n<\/tr>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Neuland Laboratories Against Other Healthcare Sector Stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Neuland_Laboratories_Compares_Against_Its_Healthcare_Sector_Peers\"><\/span><strong>How Neuland Laboratories Compares Against Its Healthcare Sector Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets Neuland Laboratories against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P\/E, ROE and debt to equity, calculated across the 2 peer companies.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Company<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">P\/E<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">27,580<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">55.41<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">19.42%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.16<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/innovacap\/innova-captab-ltd-share-price-today\">Innova Captab<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">7,275<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">47.23<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">12.92%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.32<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/jagsnpharm\/jagsonpal-pharmaceuticals-ltd-share-price-today\">Jagsonpal Pharmaceuticals<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1,586<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">34.89<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">15.60%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.03<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>Peer average (2 companies)<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">&#8211;<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>41.06<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>14.26%<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>0.17<\/strong><\/td>\n<\/tr>\n<\/table>\n<p>Against this peer set, Neuland Laboratories&#8217;s 19.42% ROE is above the 14.26% peer average, and its P\/E of 55.41x runs above the peer average of 41.06x. Neuland Laboratories&#8217; 55.41x P\/E is above the 37.53x Industry P\/E, a premium built on a strong 19.42% ROE, though a 14.72x price to book leaves little room for disappointment.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Makes_Neuland_Laboratories_Worth_Watching_in_Healthcare\"><\/span><strong>What Makes Neuland Laboratories Worth Watching in Healthcare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Strong ROE:<\/strong> A 19.42% ROE is well above most Healthcare peers covered in this series.<\/li>\n<li><strong>Low leverage:<\/strong> A debt to equity ratio of 0.16 is comfortable for an API manufacturer.<\/li>\n<li><strong>Rich valuation:<\/strong> A 55.41x P\/E against a 37.53x Industry P\/E, alongside a 14.72x price to book, is demanding.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_Valuation_Is_It_Justified\"><\/span><strong>Neuland Laboratories Valuation: Is It Justified?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neuland Laboratories&#8217; 55.41x P\/E is above the 37.53x Industry P\/E, a premium built on a strong 19.42% ROE, though a 14.72x price to book leaves little room for disappointment. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/nelcast-best-stock-in-its-sector\">Is Nelcast the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Neuland Laboratories and other Healthcare sector stocks.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Track_Neuland_Laboratories_Before_You_Invest\"><\/span><strong>How to Track Neuland Laboratories Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Before deciding whether Neuland Laboratories deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.<\/p>\n<ol>\n<li>Open the Univest Screener and search for Neuland Laboratories to view live price, valuation ratios, and peer comparisons within the Healthcare sector.<\/li>\n<li>Compare its P\/E, P\/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.<\/li>\n<li>Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.<\/li>\n<li>Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neuland Laboratories earns a place in the best stock in its sector conversation on the strength of a 19.42% ROE and a P\/E of 55.41x against a 37.53x Industry P\/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h3><span class=\"ez-toc-section\" id=\"Is_Neuland_Laboratories_the_best_stock_in_its_sector\"><\/span><strong>Is Neuland Laboratories the best stock in its sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories has a 19.42% ROE and trades at 55.41x P\/E against a 37.53x Industry P\/E, and compares above the peer average ROE of 14.26% in this article&#8217;s named comparison, so the answer depends on what an investor is prioritising.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Neuland_Laboratories\"><\/span><strong>What is the current share price of Neuland Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories was trading at Rs 21,500.00 on the NSE as of 05 October 2026, within its 52-week range of Rs 11,500.00 to Rs 24,225.00.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Neuland_Laboratories_belong_to\"><\/span><strong>What sector does Neuland Laboratories belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories is classified under the Healthcare sector on Univest.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Neuland_Laboratories_compare_to_its_sector_peers_on_PE\"><\/span><strong>How does Neuland Laboratories compare to its sector peers on P\/E?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories&#8217;s P\/E of 55.41x is above the 41.06x average of the 2 named peers compared in this article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Neuland_Laboratoriess_return_on_equity\"><\/span><strong>What is Neuland Laboratories&#8217;s return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories reported a return on equity of 19.42%, which is above the 14.26% average of its named peers in this comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_invest_in_Neuland_Laboratories_based_on_its_sector_position\"><\/span><strong>Should I invest in Neuland Laboratories based on its sector position?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Neuland Laboratories&#8217;s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.<\/p>\n<p>{&#8220;@context&#8221;: &#8220;https:\/\/schema.org&#8221;, &#8220;@type&#8221;: &#8220;FAQPage&#8221;, &#8220;mainEntity&#8221;: [{&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;Is Neuland Laboratories the best stock in its sector?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Neuland Laboratories has a 19.42% ROE and trades at 55.41x P\/E against a 37.53x Industry P\/E, and compares above the peer average ROE of 14.26% in this article&#8217;s named comparison, so the answer depends on what an investor is prioritising.&#8221;}}, {&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;What is the current share price of Neuland Laboratories?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Neuland Laboratories was trading at Rs 21,500.00 on the NSE as of 05 October 2026, within its 52-week range of Rs 11,500.00 to Rs 24,225.00.&#8221;}}, {&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;What sector does Neuland Laboratories belong to?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Neuland Laboratories is classified under the Healthcare sector on Univest.&#8221;}}, {&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;How does Neuland Laboratories compare to its sector peers on P\/E?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Neuland Laboratories&#8217;s P\/E of 55.41x is above the 41.06x average of the 2 named peers compared in this article.&#8221;}}, {&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;What is Neuland Laboratories&#8217;s return on equity?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Neuland Laboratories reported a return on equity of 19.42%, which is above the 14.26% average of its named peers in this comparison.&#8221;}}, {&#8220;@type&#8221;: &#8220;Question&#8221;, &#8220;name&#8221;: &#8220;Should I invest in Neuland Laboratories based on its sector position?&#8221;, &#8220;acceptedAnswer&#8221;: {&#8220;@type&#8221;: &#8220;Answer&#8221;, &#8220;text&#8221;: &#8220;Neuland Laboratories&#8217;s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.&#8221;}}]}<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Is Neuland Laboratories the best stock in its Healthcare sector? A data-driven comparison against named peers on P\/E, ROE and more.<\/p>\n","protected":false},"author":34,"featured_media":285833,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[5839,1019],"class_list":["post-285835","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-sector-stocks","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["285833"],"rank_math_title":["Is Neuland Laboratories the Best Stock in Its Sector? A Look at the Numbers"],"rank_math_description":["Is Neuland Laboratories the best stock in its Healthcare sector? A data-driven comparison against named peers on P\/E, ROE and more."],"rank_math_focus_keyword":["Is Neuland Laboratories the Best Stock in Its Sector? A Look at the Numbers"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/is-neuland-laboratories-the-best-stock-in-its-sector-a-look-at-the-numbers.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/285835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=285835"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/285835\/revisions"}],"predecessor-version":[{"id":285836,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/285835\/revisions\/285836"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/285833"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=285835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=285835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=285835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}